Cannabinoids are a group of compounds that mediate their effects through cannabinoid
receptors. The discovery of Δ9-tetrahydrocannabinol (THC) as the major psychoactive …

Acute noncompressive myelopathies have been recognized since the nineteenth century. 1
The terms myelitis and myelopathy are often used interchangeably, but have different …

Cannabinoids are a group of compounds present in Cannabis plant (Cannabis sativa L.).
They mediate their physiological and behavioral effects by activating specific cannabinoid …

Background Trigeminal neuralgia is one of the most characteristic and difficult to treat
neuropathic pain conditions in patients with multiple sclerosis. The present narrative review …

Historically and anecdotally cannabinoids have been used as analgesic agents. In recent
years, there has been an escalating interest in developing cannabis-derived medications to …

Introduction: Cannabinoids such as▵-9-THC and CBD can downregulate the immune
response by modulating the endocannabinoid system. This modulation is relevant for the …

Chronic pain is highly prevalent in multiple sclerosis (MS). Pain heterogeneity may
contribute to poor treatment outcomes. The aim of this study was to characterize pain …

Objective. The aim of our study was to better investigate the role of Sativex® in improving
pain in multiple sclerosis (MS) patients by means of either clinical or neurophysiological …

Immune cell infiltration to the brain's territory was considered for decades to reflect a
pathological process in which immune cells attack the central nervous system (CNS); such a …

Symptoms management in multiple sclerosis is an integral part of its care. Accurate
assessment and addressing the different symptoms provides increased quality of life among …